Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ah, mick, is there a point to your posts?
last attempt to scare us out?
I was reading about what was an 8k item. There is not clear line, but one sort of rule of thumb was that an order making a 10% difference to revenue or profit would be 8kable. I'm not sure these items would meet that threshold, but maybe.
that makes sense railrider. We'll see what happens. To Ian, I realize they are market makers, but market makers make money on the spread. If it was two different market makers, normally one would back off to establish a normal looking spread. the MMs don't make money on a hundredth of a cent spread either.
My feed has this at .9349 bid and
.9350 asked. This is obviously not real. No one would not buy or sell for a hundredth of a cent at 1000 shares. That's 10 cents difference if my math is right. I wonder what's going on.
One thing no one seems to have noticed is the last line of the financials. No subsequent events to the end of October. So, whatever news of contracts with customers must have happened since October 31. There may not be any 8k news.
I didn't see notice of this on Yahoo or on any of the normal PR sites. But I think this may be significant. The quoted part below, is from the last page of the release, under subsequent events, about a company they had acquired, RMT. It mentions autism and opioid addition. "RMT
holds various assets including (i) models, methods and protocols for collection birthing tissue and DNA
samples, (ii) patient registry models, methods and protocols to collect clinical outcomes and electronic
medical records, and (iii) designs and methodologies relating to bone marrow aspirate kits, large joint
injection kits, degenerative disc disease post-microdiscectomy injection kits, an allogenic stem cell
products for degenerative disc disease, autism, facet joint, IV treatment of opioid addition, and (iv)
other assets. Under the terms of the Acquisition Agreement, PAI will merge with RMT, the surviving
corporation will become a wholly owned subsidiary of the Company"
Saw your headline RR and checked my feed. No trade like that on PRED. Then I checked the rest of your post. You're a tease, RR.
Wow, railrider, you've got the touch. Keep this up and you'll be a gazillionaire.
Right, TL52000, that's what I thought you meant and I agree. The waiting is irritating but it is what it is, and as I've said to Orangeman before, the valuation of a stock is based on total outstanding, not float.
Would you care to clarify, TL52000? Done with the stock or done with responding to Orangeman?
Demain and Bgrass are constantly talking about Stuie lying about the news as if this should be a reason to not buy. The possibility that Stuie is lying is simply a risk factor like any other and can be assessed like any other. My assumption is that the fortune 500 company that Stuie is talking about is Caterpillar. Why? Because he mentioned that he was in talks with the largest manufacturer of construction equipment and also that he had talked to customers in Athens Georgia where CAT has a plant. That plant makes parts which are distributed to assembly plants all over the country and world. According to the release, they are investing 500k in building a building to apply INTK's material. Not a big investment for CAT but it could be they are applying INTK's material to, say mufflers, or muffler covers, to protect from burn injuries. A likely use, this was considered at one time for motor scooters on which mufflers cause burn injuries frequently. (I know, I had one.)
If so, this could generate profits of say 22 million a year over time. That's about a penny a share which would give a market cap of about 20 times that, with a growth factor, would would be about 20 cents a share. I'm just making up numbers and could be way off so you can feel free to substitute your own numbers. That may take two years so reduce to present value using whatever method you choose. So let's say you believe that the chances that Stuie is lying is about 75%. That simply means you reduce the 20 cents a share to 5 and evaluate whether that is a good bet for you. (As always, check my math.)
For my money it is a good bet, but your mileage may differ.
This stock reminds me of an old Kinks song.
from your ears to God's mouth. Oh, wait, I got that wrong.
it was a typo by Anathazar. He meant mm (market maker) anD they refuse to hire one.
I understand, anthazar. My only point was I understand why the market did not react more strongly to this news.
Thanks Pelco, I didn't know that. Thanks for the info.
I'm not sure this is as big as we devotees think it is. Consider that Sorrentino moved from one part time job with PRED to another. We may think it is a big move, and maybe it is, but he is still working full time for Pfizer from this PR. So what does it mean really? I think the company has great prospects, but I don't think this PR is going to convince anyone who has not already been convinced.
It is interesting that no one left on the management team. In fact, there was one guy added. It is possible that the chapter 11 was filed to protect them from creditors that Daniel left them with while they get some customers or financing. It's not a good thing, but it may not be bad either.
Also, Power Partners, a company that manufactures heating and cooling equipment. All could be potential customers. It makes sense.
Isn't Athens where the University of Georgia is? I only ask because the tweet say many new customers, but also new talent. I wonder what that is about. Also the eight largest business in Athens include Pilgram's Pride and, wait for it, a manufacturing facility of Caterpillar. https://livability.com/ga/athens/business/8-top-employers-in-athens-ga
Looks like chapter 11, reorganization. Apparently to protect themselves against some suits. Not good, but we still have a chance. https://www.streetinsider.com/SEC+Filings/Form+8-K+ALLIANCE+BIOENERGY+PLUS%2C+For%3A+Oct+22/14734851.html
According to the website, three on the scientific advisory board, plus the one they added today, and two on the financial advisory board.
ekkonig asked,
So does this make it 20 or 30 people now as a PRED advisor?
It will be new shares, I'm pretty sure of that. But will this acquisition open up a whole new market in spinal treatment with their stem cells, which I expect. If so, then the revenue from this new area will be accretive to earnings by more than the dilution. I expect that both sides saw the synergy. PRED got the expertise in spinal and disc disease plus the data from RMT's 13 clinics. RMT will get PRED's stem cell supply and the power of being with a bigger company. From the PR RMT seems to have 13 clinics which will be generating income so there is a good chance it is accretive. But you're right, we need more info which we should get if they plan to uplist. I suspect they will have to release that info, if not in the form 10, then soon after.
I don't know about the form 10, but dilution is an interesting question. I assume you're talking about the 10 million shares for the acquisition, since there is no other dilution that I am aware of. Shares for an acquisition are only dilutive if the acquisition is not accretive to earnings. We just don't know at this point if it will be accretive.
If you're not a dissembler, then my suggestion is don't look at this thing every day. As I said before, when a stock starts earning money it moves from quarter to quarter, from earnings report to earnings report. The rest is just noise.
Clipped, you're such a dissembler. If half of what Stuie is saying is true, in two years or so this will be worth a dime. That means about 220 million market cap, about 15 million in earnings, definitely doable, and most importantly a 20 bagger for you. Just have patience. But, as I suspect and you know, you're not here to get a 20 bagger, are you?
Pred acquired a company that treats spinal issues. And now a message from my sciatic nerve. HURRY THE HELL UP, WILL YOU!
So far, going in the right direction for your buy. Pred is showing a little life today. Here's hoping it will last.
Interesting that they named the customer. They haven't done this for a while. I assume that means that Volvo okayed it. This may be important. I may have been wrong about Stuie.
A lot of people on this board seem disappointed that the stock price didn't jump after getting current. This is not unusual in my experience. Before making money, stocks trade on dreams. After, they start to trade on earnings. Although it was great that the company had positive earnings and seems to have turned a corner, with 2.2 billion shares outstanding, the EPS was anemic to say the least. Someone here said the goal was to make this a 50 million revenue company. To put that in perspective, 50 million, divided by 2.2 billion is about 2 cents a share. (always check my math) Even if all that dropped to the bottom line, which it won't, those earnings would support about a 30 cent valuation plus a little for growth potential. With 50% margins, it would be 15 cents. I don't think we know what the time line on getting to 50 million revenue is, so the current valuation is not that far off what is reasonable.
The positive thing I take from this is that Stuie actually came through. He was telling the truth about getting current and about being in the black. If we assume that truth telling for Stuie is a binary, then all the other things, the deals he has entered into, the new customers the company is getting, then all that is true. That's a very good sign, but the stock price may move from quarterly earnings to quarterly earnings from now on. It may be a long, boring wait, but I have held this stock for four years, so I can hold for another four.
Well, they just announced the launch of ArtGuide, let's see if that moves the market. The headline said they announce the launch, the body said they will announce the launch at conference and that it will be available in six markets in the next few months. All of that was in the conference this week, so I'm not sure how much it means.
The company did in fact file a current report with the SEC in June of this year. All the filing said was that they had filed with the otc, but they clearly filed with the SEC.
They have made at least one acquisition, announced earlier this week, and may have made others. I didn't see the terms of the acquisition, so maybe it was made for shares. this could account for the increase in outstanding.
I had to work this afternoon, bad timing, so I couldn't listen to the presentation. Anything noteworthy? I see the replay is not up on the company's website yet, is it available anywhere yet that anyone knows about.
Thanks in advance.
In America we say diddly squat.
More seriously, I understand that the patents aren't worth anything until they are used to make money. But companies like this aren't evaluated on current earnings, but on potential. These investments aren't for everyone or for a large part of your portfolio, but they can be sound. And you may think the patents are overvalued, but that's your opinion.
But, Elkonig, you know all this. The question really is, what is your financial interest here?
I missed the first 10 minutes. Anything of note there?
There is an email address to accept questions for the company to answer during the call. It doesn't sound like there will be an opportunity to ask questions on the call, just email both before and during the call. You may want to email them and ask if it will be available on the web. It certainly seems like it would be easier. ir@wndm.com http://irdirect.net/prviewer/release/id/3310617
Yes, it does. Thanks for this, Pelco. It looks even more like we have a winner here.
Also, apparently Bart Starr used stem cells for stroke. He was referred by Kramer as well.